Cadherin-mediated interactions are integral to synapse formation and potentiation. Here we show that N-cadherin is required for memory formation and regulation of a subset of underlying biochemical processes. N-cadherin antagonistic peptide containing the His-Ala-Val motif (HAV-N) transiently disrupted hippocampal Ncadherin dimerization and impaired the formation of long-term contextual fear memory while sparing short-term memory, retrieval, and extinction. HAV-N impaired the learning-induced phosphorylation of a distinctive, cytoskeletally associated fraction of hippocampal Erk-1/2 and altered the distribution of IQGAP1, a scaffold protein linking cadherin-mediated cell adhesion to the cytoskeleton. This effect was accompanied by reduction of N-cadherin/ IQGAP1/Erk-2 interactions. Similarly, in primary neuronal cultures, HAV-N prevented NMDAinduced dendritic Erk-1/2 phosphorylation and caused relocation of IQGAP1 from dendritic spines into the shafts. The data suggest that the newly identified role of hippocampal Ncadherin in memory consolidation may be mediated, at least in part, by cytoskeletal IQGAP1/Erk signaling.
INTRODUCTION
Classic type I cadherins, including neuronal (N)-cadherin, play a critical role in the developmental organization of the brain (Redies, 2000) and synapse formation in the adult CNS (Junghans et al., 2005) . These processes are regulated by the extracellular domains mediating cell-cell adhesion in a calcium-dependent, predominantly homophilic manner (Shapiro and Colman, 1998) . Intracellularly, cadherins are anchored to the actin cytoskeleton by multiprotein complexes including b-and a-catenin (Angst et al., 2001 ) and associated with docking proteins to intracellular signaling pathways (Husi et al., 2000) , enabling the translation of cell adhesion signals into long-term cellular responses (Marambaud et al., 2003; Perron and Bixby, 1999; Widelitz, 2005) .
Earlier studies reported a role of N-cadherin in synaptic potentiation. By applying blocking antibodies or antagonistic peptides containing the His-Ala-Val (HAV) motif for classic type I cadherin dimerization, Tang et al. (1998) observed a significant impairment of hippocampal long-term potentiation (LTP). Bozdagi et al. (2000) subsequently reported similar findings with N-cadherin blocking antibodies in a model of late-LTP and additionally demonstrated that synaptic potentiation increases the synthesis and recruitment of N-cadherin to newly formed synapses. These findings suggested that N-cadherin-mediated cell adhesion may contribute to learning and memory (Hagler and Goda, 1998; Murase and Schuman, 1999) .
A role of cadherins in memory has not yet been documented. Contrary to expectation, mice lacking the classical type II cadherin-11 displayed enhanced LTP and normal spatial learning (Manabe et al., 2000) . On this basis, it was suggested that cadherins might be functionally redundant, thereby masking the effects of individual members (Togashi et al., 2002) . The role of classical type I cadherins, such as N-cadherin, could not be studied with constitutive gene knockouts due to embryonic lethality (Radice et al., 1997) . By using an alternative approach, conditional expression of dominant-negative protein in the adult brain, Edsbagge et al. (2004) attempted to nonselectively impair the function of type I cadherins. Surprisingly, these mice did not show any alterations of synaptic potentiation or spatial learning. It should be noted, however, that N-cadherin was produced normally in the brain of transgenic mice, and that the expected functional consequences of the transgene could not be demonstrated due to its expression later in life.
To overcome possible compensatory or developmental effects of genetic manipulations, we employed acute injection of antagonistic peptides containing the His-AlaVal motif (HAV-N) to examine the role of N-cadherin in learning and memory. HAV-N containing aspartic (D) amino acid flanking the HAV sequence was shown to specifically bind to N-cadherin when compared to other classic cadherins (Williams et al., 2000) . On this basis as well as their thorough characterization in electrophysiological experiments (Tang et al., 1998) , we selected HAV-N and a scrambled peptide (HAV-S) to perform these studies. The hippocampally dependent contextual fear conditioning paradigm served to establish the effect of HAV-N on memory formation, retrieval, and extinction. Furthermore, we investigated the interference of HAV-N with postadhesion signaling associated with N-cadherin complexes, including extracellular signal-regulated kinases 1 and 2 (Erk-1/2) and IQGAP1 (Derycke and Bracke, 2004) .
We demonstrated a role of hippocampal N-cadherin in early mechanisms leading to consolidation of long-term contextual fear memory. Biochemical findings suggested that these mechanisms include the activation of a discrete fraction of cytoskeletal Erk-1/2 and its interaction with IQ-GAP1. N-cadherin-mediated cytoskeletal IQGAP1/Erk-1/2 signaling may be important for synaptic remodeling associated with memory.
RESULTS

HAV-N Impairs Memory Formation without Affecting Retrieval or Extinction
Mice were implanted with microcannula into the dorsal hippocampus and subjected to context and tone-dependent fear conditioning. Dorsohippocampal injection of HAV-N immediately after training dose-dependently impaired contextual freezing [F (4,45) = 4.57, p < 0.05] during the memory test performed 24 hr later ( Figure 1A ). Tonedependent fear conditioning ( Figure 1B) was not affected by any of the applied treatments [F (4,45) = 1.43, p = 1.22]. The specificity of the most effective dose (750 ng/mouse) was compared to a group receiving the same amount of a scrambled peptide (HAV-S) or vehicle. Only HAV-N impaired long-term memory of contextual fear, as indicated by a significant reduction of freezing [F (2,33) = 6.16, p < 0.01] and increase of mean activity [F (2,33) = 3.251, p < 0.05] during the contextual memory test performed 24 hr later ( Figure 1C) . HAV-N injected in separate groups of mice immediately posttraining did not affect freezing determined 1 hr later [F (2,30) = 0.57, p = 0.75], indicating that HAV-N did not affect short-term memory ( Figure 1D ). Additional time course studies showed that HAV-N impaired long-term memory formation when injected 15 min before training [F (2,28) = 4.31, p < 0.01]; however, injections performed 60 min posttraining did not significantly affect consolidation, as indexed by freezing behavior [F (2,29) = 1.98, p = 0.93; Figure 2A ]. Pretraining injections of HAV-N did not reveal any effects of the peptide on mean activity [F (2,28) = 0.62, p = 0.87] or activity burst to the shock [F (2,28) = 0.34, p = 0.43]. The group values (in cm/s) for activity were as follows: vehicle 11.5 ± 1.3, HAV-S 11.8 ± 0.8, HAV-N 11.1 ± 0.9; and for shock response: vehicle 41.9 ± 5.6, HAV-S 43.3 ± 4.7, HAV-N 39.7 ± 4.9.
To test the effect of N-cadherin signaling on memory retrieval and extinction, HAV-N was injected 15 min before the test ( Figure 2B ) or immediately after nonreinforced trials ( Figure 2C ), respectively. Neither treatment affected freezing behavior when compared to the control injections [pretest: F (2,27) = 1.79, p = 0.98; extinction: F (8,135) = 0.56, p = 1.85]. These results indicated that the HAV-N antagonistic peptide significantly impaired memory consolidation without affecting retrieval or extinction of contextual fear.
HAV-N Blocks N-Cadherin Dimerization HAV-N is expected to interfere with N-cadherin function by decreasing the dimerization of N-cadherin molecules. By employing one-way ANOVA with factor Group (naive, vehicle, HAV-S, and HAV-N) for each dose and time point or two-way ANOVA with Treatment and Time as factors, we analyzed the dorsohippocampal levels of N-cadherin monomers and dimers after HAV-N treatment ( Figures  3A-3D ). All mice except for those of the naive group were exposed to fear conditioning and injected immediately thereafter with vehicle, HAV-S or HAV-N. Immunoblot signals of total dorsohippocampal lysates showed a significant increase of N-cadherin monomers after fear conditioning (Figures 3A and 3B) in all groups when compared to the naive [Group: F (18, 76) = 18.7, p < 0.01] group independently of treatment. Considering the very short lifetime (Klingelhofer et al., 2002) and low level of cadherin dimers, the effect of HAV-N on dimerization was examined under nonreducing conditions (Àb-mercaptoethanol; Àb-ME). This approach, selected to preserve disulfide bonds promoting and stabilizing cadherin dimerization (Makagiansar et al., 2002) , enhanced dimer detection in the control groups ( Figure 3C ). N-cadherin dimers in the membrane fractions were also significantly elevated after fear conditioning (vehicle and HAV-S groups) when compared to naive mice. HAV-N significantly impaired N-cadherin dimer formation depending on the dose [F (3, 56) = 116.446, p < 0.001] and postinjection time [F (2,56) = 63.067, p < 0.001]. Post hoc analyses revealed significant effects of 500 ng/mouse ( Figure 3D ) and 750 ng/mouse ( Figures 3C and 3D ) of HAV-N at the time points 15 and 30 min posttraining when compared to the other groups. Analyses of membrane fractions of dorsohippocampal lysates obtained from naive, vehicletreated, or HAV-S-treated mice showed weak but clear bands at 230 kDa under nonreducing but not under reducing (+bME) conditions, indicating N-cadherin dimers ( Figure 3C ). This band was not detectable in lysates obtained 15 and 30 min after HAV-N injection and reappeared, although with diminished intensity in the 500 [F (2,12) = 4.65, p < 0.05] and 750 ng groups [F (2,12) = 4.12, p < 0.05], after 1 hr. The decrease of N-cadherin dimerization by HAV-N ( Figure S1C in the Supplemental Data available with this article online) was confirmed by a mouse monoclonal N-cadherin antibody (clone G-C4, Sigma). These results showed that the behaviorally effective doses of HAV-N prevented N-cadherin dimerization in a restricted time window posttraining. Notably, the effect of HAV-N on N-cadherin dimerization was dissociable from N-cadherin production. Thus, N-cadherin dimerization early after fear conditioning and its later upregulation may independently contribute to the early and late biochemical processes leading to long-term memory formation.
Attenuated N-cadherin cell-cell adhesion activates the small GTP-ase Rac1 (Charrasse et al., 2002) , whereas disruption of cell-cell adhesion may alter the subcellular distribution of N-cadherin and b-catenin (Rhee et al., 2002) . To examine whether HAV-N affected these parameters associated with N-cadherin function, we determined the levels of N-cadherin and b-catenin as well as the localization and activity of Rac1 (see Supplemental Experimental Procedures) in several subcellular hippocampal fractions. Immunoblot analyses indicated that HAV-N did not significantly affect b-catenin-mediated signaling or N-cadherin redistribution under these conditions (Figures S1A and S1B). However, the activity of Rac1, a protein recruited to the membrane when cell adhesion is weakened (Kaibuchi et al., 1999) , was elevated in the membrane fractions ( Figure S1D ). Thus, some effects of decreased N-cadherin dimerization, such as activation of Rac1, have been reproduced by HAV-N. Expectedly, the peptide did not mimic the alterations accompanying severely disrupted cell-cell adhesion typically involving N-cadherin and b-catenin redistribution.
Hippocampal N-Cadherin Levels Increase after Contextual Fear Conditioning Increased levels of N-cadherin may contribute to LTP and possibly memory consolidation by strengthening cell-cell adhesion. On this basis, we examined the levels of N-cadherin at different time points after training. In order to provide a maximal signal/noise ratio, we employed a dilution of anti-N-cadherin antibody that gave just detectable signals. N-cadherin levels significantly increased after fear conditioning [F (7,40) = 5.97, p < 0.01]. An upregulation was observed shortly after training, peaking 1 hr later and exhibiting a persistent elevation, particularly in the CA2 subfield, up to 5 days posttraining ( Figures 4A-4C ). The specificity of N-cadherin production after fear conditioning was shown in two experiments. To control for the persistent N-cadherin elevation after conditioning, a group of mice exposed to daily extinction trials leading to fear reduction was introduced (Fischer et al., 2004) . Nonreinforced trials abolished the increase of Ncadherin levels observed 5 days posttraining (Figures 4A and 4C) , suggesting that the upregulation of N-cadherin levels were specific for conditioning relative to extinction. Whether the observed downregulation of N-cadherin contributes to fear extinction remains to be established. In a separate experiment, a group of mice was exposed to an inverse presentation of training stimuli so that an immediate shock was followed by tone and context. This group exhibited significantly lower freezing than the paired group [F (2,27) = 8.45, p < 0.01; Figure 4D ] as observed in our earlier work Sananbenesi et al., 2002) and did not show upregulation of N-cadherin levels comparable to the paired context-tone-shock group [F (2,15) = 4.78, p < 0.01, Figure 4E ].
Taken together, these findings demonstrated a longlasting increase of N-cadherin levels in hippocampal neurons specifically accompanying consolidation of associative learning.
HAV-N Selectively Disrupts the Activation of Erk-1/2 Associated with the Cytoskeleton N-cadherins are associated with a number of signaling molecules within multiprotein complexes linking the cell membrane to the actin cytoskeleton (Husi et al., 2000) . On this basis we hypothesized that the memory-impairing actions of HAV-N may be due to interference with signal transduction pathways involved in memory formation. We tested this possibility by monitoring the activation of Erk-1/2, cAMP-dependent protein kinase binding protein (CREB), p38 mitogen-activated protein kinase (p38MAPK), and stress-activated protein kinase (SAPK) in hippocampal subcellular fractions prepared 1 hr after fear conditioning and immediate posttraining injection with HAV-N, HAV-S, or vehicle. In all subcellular fractions, pErk-1/2 levels increased [vehicle versus naive: membrane: t (7) = 5.17, p = 0.01; cytosol: t (7) = 3.95, p = 0.05; cytoskeleton: t (7) = 4.82, p < 0.01] after training ( Figure 5 ). Analyses of immunoblots demonstrated significant effects of HAV-N on Erk-1/2-mediated signaling ( Figures 5A-5C ). Whereas the levels of total Erk-1/2, but not the pErk/Erk ratio [F (2,10) = 0.929, p = 0.426], were increased in the membrane fraction [total Erk: F (2,10) = 7.42, p < 0.01; Figure 5A , lower panel], the phosphorylation of Erk-1/2 within the cytoskeletal protein pool ( Figure 5C , upper panel) was significantly reduced [F (2,10) = 6.975, p < 0.01]. In contrast to pErk-1/2, the activation of p38MAPK and pSAPK in the cytoskeleton, and CREB in the nucleus, was not significantly affected ( Figures S2A-S2C ) at the corresponding time point.
Given that both pErk-1/2 (Sananbenesi et al., , 2003 and N-cadherin levels peak 1 hr after fear conditioning, we selected this time point to examine by immunofluorescence whether these molecules colocalize within the hippocampus. When compared to naive mice ( Figure 6A ), mice exposed to fear conditioning exhibited a marked upregulation of pErk-1/2 and N-cadherin in the pyramidal cell layer and str. radiatum ( Figure 6B ). Analyses of high-magnification captures revealed that 65% ± 8% of pyramidal neuron soma within the hippocampal CA1 subfield were positive for both N-cadherin and pErk-1/2 (Figures 6A and 6B, bottom panels). N-cadherin signals typically representing synaptic puncta were also observed in 75% ± 11% of pErk-1/2-positive apical dendrites ( Figure 6 , lower panel). It should be noted that pErk-1/2 showed 53% ± 7% and 57% ± 5% overlap in the soma and dendrites, respectively (data not shown). Thus, most N-cadherin signals colocalized with pErk-1/2, whereas a subset of pErk signals colocalized with N-cadherin. This finding was expected given the coupling of Erk-1/2 to a vast number of receptor molecules (Fukunaga and Miyamoto, 1998) .
Taken together, these data showed that, although learning activated Erk-1/2 in all subcellular fractions, HAV-N selectively impaired the fear conditioning-induced phosphorylation of cytoskeletally bound Erk-1/2. Notably, this delayed effect (1 hr posttraining) probably resulted from an early disruption of N-cadherin interactions, given that newly synthesized N-cadherin did not rescue the phosphorylation of Erk-1/2 at the examined time point. The colocalization of pErk-1/2 and N-cadherin support the view that these proteins may interact, probably indirectly, within individual pyramidal cells.
HAV-N Triggers Redistribution of IQGAP1
Several docking proteins compartmentalize Erk-1/2 with upstream regulators, thereby tightly controlling its activity. On the basis of its ability to bridge cadherin-mediated adhesion to cytoskeletal alterations and Erk-1/2 signaling (Brown and Sacks, 2006; Roy et al., 2004) , we hypothesized that IQGAP1 may be involved in the effects of HAV-N on pErk-1/2. HAV-N injections differentially affected IQGAP1 levels in hippocampal subcellular fractions ( Figures 7A-7C ). The significant decrease and increase of IQGAP-1 in the cytosolic [F (2,10) = 4.17, p < 0.05] and cytoskeletal [F (2,10) = 4.302, p < 0.05] fractions ( Figures 7B and  7C) , respectively, indicated redistribution of IQGAP1 from the cytosol to the cytoskeleton in response to HAV-N. However, the peptide did not affect [F (2,10) = 1.085, p = 0.374] membrane levels of IQGAP1 ( Figure 7A ). In response to fear conditioning, the distribution of IQGAP1 between subcellular compartments of vehicle controls was not altered [ Figure 7D ; membrane: t (7) = 0.177, p = 0.65; cytosol: t (7) = 0.251, p = 0.73; cytoskeleton: t (7) = 0.213, p = 0.69], suggesting that maintaining the localization of IQGAP1 during learning may be an important role of N-cadherin. Such effects were not observed in identically treated but nontrained mice ( Figure S3 ), confirming that HAV-N exerts maximal activity when applied concurrently with fear conditioning.
To study in more detail the relationship between cytoskeletal IQGAP1 and pErk-1/2, we performed time course and dose-response studies with HAV-N. In the same cytoskeletal preparations, HAV-N decreased and increased the levels of pErk-1/2 and IQGAP1, respectively, with maximal effects observed 1 hr after training/injection and only with the behaviorally effective doses of 500 and 750 ng/mouse ( Figure 7E Given that increased concentrations of IQGAP1 negatively regulate Erk-1/2 phosphorylation (Roy et al., 2004) , these results suggest that HAV-N may disrupt the activity of cytoskeletal Erk-1/2 by increasing the levels of IQGAP1 bound to the cytoskeleton.
HAV-N Attenuates the Interactions between N-Cadherin, IQGAP1, and Erk
We further examined whether HAV-N affects the functional interactions between N-cadherin, IQGAP1, and Erk. As cytoskeletal preparations contain high levels of denaturating agents and low protein amount, we performed coimmunoprecipitation studies using total dorsohippocampal lysates. The samples were prepared from fearconditioned mice injected posttraining with vehicle, HAV-S (750 ng), or HAV-N (750 ng) and euthanized 1 hr later. N-cadherin, IQGAP1, Erk-1/2, and pErk-1/2 were coimmunoprecipitated and detected by each of the employed antibodies, showing that these proteins interact in the dorsohippocampal tissue ( Figures 8A-8D) . We detected only Erk-2 in the immunoprecipitates with Ncadherin and IQGAP1 ( Figures 8A and 8B) , despite the presence of the Erk-1 isoform in the input samples ( Figure 8E) . Analyses of N-cadherin-bound complexes demonstrated a significant decrease of pErk-2 (p < 0.01), Erk-2 (p < 0.01), and IQGAP1 (p < 0.01) in response to HAV-N treatment. Similarly, significantly lower levels of N-cadherin (p < 0.01) were detected in immunoprecipitates performed with IQGAP1, pErk-1/2, and Erk-1/2 (Figures 8B-8D ). IQGAP1 complexes with pErk-2 were significantly increased after fear conditioning in vehicle and HAV-S samples (p < 0.05), whereas HAV-N caused a reduction of pErk-2 bound to IQGAP1 (p < 0.01) despite an increased interaction with total Erk-2 (p < 0.01). These observations were confirmed with immunoprecipitates employing pErk-1/2 and Erk-1/2 antibodies ( Figures 8C  and 8D ). Consistent with increased pErk levels in all cellular fractions, input pErk levels in the total lysates was expectedly higher. Supporting specific interaction with IQGAP1, pErk was not enhanced in N-cadherin ( Figure 8A ) or control IgG ( Figure 8E ) coimmunoprecipitates. Furthermore, the level of total Erk was not increased in the IQGAP1 complexes ( Figure 8B ).
These findings indicated that N-cadherin, IQGAP1, and Erk-2 form complexes in the dorsal hippocampus. Notably, although IQGAP1 levels were not affected by fear conditioning, its interaction with Erk-2 was significantly enhanced. The composition of N-cadherin/IQGAP1/Erk-2 complexes was disrupted by HAV-N, possibly as a result of an impaired N-cadherin dimerization.
HAV-N Inhibits Erk-1/2 Phosphorylation and Removes IQGAP1 from Dendritic Spine Heads
To study in more detail the localization of N-cadherin, Erk-1/2, and IQGAP1 and their relationship to N-cadherin function, we employed primary cortical cultures. We first established that N-cadherin and Erk-1/2 colocalize with IQGAP1 in these cultures ( Figures 9A and 9B) . NMDAinduced activation of these cells resulted in a significant (p < 0.001) rise of pErk-1/2 levels that was completely blocked by pretreatment with HAV-N but not HAV-S (Figures 9C and 9D ). Under the same conditions, HAV-N did not affect total IQGAP1 levels, as indicated by fluorescence intensity, but resulted in decreased IQGAP1 in dendritic spines and an accumulation in dendritic shafts (Figures 9E-9G ), revealed by a decrease of spine/shaft ratio (p < 0.01) of IQGAP1 distribution. These findings replicated our key in vivo observations indicating a role of Ncadherin in IQGAP1/Erk-1/2 signaling and suggested that the decrease of pErk-1/2 by HAV-N may be associated with the removal of IQGAP1 from dendritic spine heads and its increase in the dendritic shafts. Owing to the similarities in N-cadherin function and its interactions with synaptic proteins in hippocampal and cortical neurons (Nuriya and Huganir, 2006) , as well as consistencies between the in vitro and in vivo data, we hypothesize that the identified role of N-cadherin in IQGAP1/Erk signaling encompasses both cortical and hippocampal plasticity.
DISCUSSION
We demonstrated an important role of N-cadherin in the consolidation of hippocampally dependent memory and associated neuronal signaling mechanisms. Biochemically, N-cadherin was identified as a regulator of the distribution of IQGAP1 and activation of a distinctive, learninginduced, cytoskeletal fraction of pErk-1/2. In turn, learning mechanisms led to long-term upregulation of hippocampal N-cadherin levels. Above all, this increase persisted in the CA2 hippocampal subfield known to transmit delayed excitatory signals to CA1 neurons (Sekino et al., 1997) and maintain long-range axonal connectivity (Zaidel, 1999) , the link to the basolateral amygdala being particularly significant for the integration of emotional and cognitive processing (Benes et al., 2004; Nakao et al., 2004) . The N-cadherin antagonistic peptide HAV-N disrupted fear conditioning-induced N-cadherin dimerization and cytoskeletal Erk-1/2 signaling but not N-cadherin upregulation. This observation is not surprising given that plasticity-induced increase of N-cadherin requires de novo protein synthesis mediated by nuclear effects of cAMP-dependent protein kinase signaling , a pathway not affected by the employed HAV-N treatment. Disulfide bonds (Makagiansar et al., 2002) and other interactions (Troyanovsky et al., 2006) promote and stabilize cadherin dimerization. HAV peptides are thought to prevent these interactions, thereby disrupting N-cadherin dimerization and postadhesion signaling (Harrison et al., 2005; Renaud-Young and Gallin, 2002; Shapiro et al., 1995) . Accordingly, it was demonstrated that the formation of cadherin dimers is required for cadherin-mediated signaling (Kim et al., 2005) . HAV-N may also attenuate Ncadherin dimerization, at least in part, by causing redistribution of the N-cadherin/Erk-1/2 docking protein IQGAP1 known to stabilize surface N-cadherin molecules (Noritake et al., 2005) . We confirmed those observations in vivo, by showing that selected doses of HAV-N transiently impaired N-cadherin dimerization, pErk-1/2-mediated signal transduction, and IQGAP1 distribution in hippocampal neurons. Importantly, only the doses of HAV-N that disrupted fear conditioning caused these biochemical effects, suggesting a link between the observed molecular and behavioral alterations.
HAV-N significantly impaired memory formation of contextual fear at selected doses relative to training. Ushaped dose-response curves are typically observed with in vivo pharmacological studies employing biologically active peptides (Calabrese and Baldwin, 2003) . Although the mechanisms of such effects are not known in detail, it may be speculated that at higher doses the HAV-N molecules might interact with one another, with other related cadherins, or with unrelated proteins containing N-cadherin motifs, such as fibroblast growth factor receptors (Williams et al., 2001) .
The involvement of N-cadherin in LTP induction but not LTP maintenance (Tang et al., 1998) , when N-cadherin production and synaptic recruitment significantly increase , is consistent with our in vivo experiments. Despite this early involvement, N-cadherin mediated the development of late but not early LTP, as revealed by the use of blocking antibodies . Similarly, in our study HAV-N impaired long-but not short-term memory. These results indicated a role of Ncadherin in early biochemical events initiating memory consolidation (Miyamoto, 2006) . Lack of effects of HAV peptides at later time points after training and during retrieval or extinction does not exclude a role of learning-induced N-cadherin in these processes, as posttraining actions of HAV-N may be limited by several factors. First, in response to synaptic activity, N-cadherin levels increase in the form of molecularly modified, stable, protease-resistant dimers . Such modifications could limit the actions of HAV-N on dimerization of newly synthesized N-cadherin and behavior. Second, the effects of HAV-N critically and inversely depend on the concentration of extracellular Ca 2+ (Tang et al., 1998) . The transition of calcium ions from extracellular spaces into the cell during early phases of memory formation may enhance the efficiency of HAV peptides during these phases, as suggested earlier (Tang et al., 1998) . Thus, elevated N-cadherin levels, stabilization of N-cadherin molecules, or weaker calcium ion fluctuations may result in diminished efficiency of HAV-N. Consistent with the latter possibility, extinction mechanisms, although shared to some extent with those involved in conditioning, appear to recruit a more limited set of biochemical pathways (Berman and Dudai, 2001; Lin et al., 2003) . Furthermore, processes other than dimerization, including cleavage or decreased N-cadherin production, could contribute to extinction. Such alterations may be required to weaken the synaptic contacts established during fear conditioning, so that acquired fear would not persist without aversive reinforcement. The potential roles of Ncadherin in the later phases of memory formation, retrieval, and extinction, remaining to be established by more potent interfering agents or transient genetic manipulations, are likely to reveal additional mechanisms associated with the function of newly synthesized N-cadherin. The significant involvement of N-cadherin dimerization in the activation of Erk-1/2, a key kinase involved in memory consolidation (Atkins et al., 1998) , was not surprising. However, the selective role of N-cadherin dimerization in the phosphorylation of a segregated, cytoskeletal fraction of Erk-1/2 (but not pCREB, p38MAPK, pSAPK, or b-catenin signaling at the same time points) was unexpected, given that signal transduction by PKA (Dell'acqua et al., (Yu and Malenka, 2003 ) also depends on their interactions with N-cadherin. Possibly, the functions of the latter pathways are predominantly regulated by N-cadherin cleavage (Reiss et al., 2005) , or alternative cascades including the Wnt pathway (De Ferrari et al., 2003) .
2006) as well as b-catenin
Contrary to the significant decrease of Erk-1/2 activation in cytoskeletal preparations of HAV-N-injected hippocampi, pErk-1/2 levels in the membrane extracts increased proportionally to the levels of total Erk-1/2 protein in this fraction. Weakening of cell-cell interactions by the antagonistic peptide may trigger the activation of Rac1 (Charrasse et al., 2002) , as confirmed here, or redistribution of other signaling molecules toward the cell membrane (Retta et al., 2006) . Although membrane interactions and docking of Erk-1/2 significantly contribute to synaptic plasticity and learning (Morozov et al., 2003; Shalin et al., 2006) , it appears that they could not compensate for the memory-impairing effect of HAV-N. Selective activation of cytoskeletal Erk-1/2 by N-cadherin may thus be required for memory formation in a nonredundant manner to membrane-docked Erk-1/2. Because the threshold for intracellular Erk-1/2 phosphorylation is markedly higher than that for membrane-bound Erk-1/2 (Harding et al., 2005) , N-cadherin interactions may selectively lower the activation threshold for Erk-1/2 bound to the cytoskeleton. Such effects may be mediated by IQGAP1, a scaffold for cadherins and cytoskeletal elements, that has recently emerged as a main regulator of cell adhesion-induced cytoskeletal rearrangement and signal transduction (Fukata et al., 2001; Noritake et al., 2005) . Fear conditioning did not affect IQGAP1 levels; however, its interaction with pErk-2, the main isoform activated by fear conditioning (Atkins et al., 1998) , was significantly enhanced. HAV-N triggered redistribution of IQGAP1 from the cytosol to the cytoskeleton and diminished N-cadherin binding to IQGAP1 and pErk, suggesting that normal N-cadherin function was required for optimal interaction of these molecules. Relatively small increases or decreases of IQGAP1 and other scaffold proteins are known to decrease Erk-1/2 activity by altering the stoichiometry of the mitogen-activated protein kinases serving as upstream Erk activators (Levchenko et al., 2000; Roy et al., 2004) . In agreement with the model proposed by Roy et al. (2005) , the enhanced binding of IQGAP1 to Erk-2 was accompanied by significantly decreased Erk-2 phosphorylation in response to HAV-N treatment. Thus, IQGAP1 may be a strong candidate for linking N-cadherin and Erk-1/2 signaling during contextual fear memory formation.
The cytoskeletal preparations employed here contained both actin and microtubules that are predominantly localized in dendritic spines and shafts, respectively (Kaech et al., 1997; Widelitz, 2005; Wilson and Keith, 1998) . To more closely determine the redistribution of IQGAP1 and its relationship to Erk-1/2 phosphorylation, we employed neuronal cultures activated by NMDA with or without pretreatment with HAV-S and HAV-N. Consistent with the in vivo generated data, HAV-N abolished the phosphorylation of pErk-1/2. At the same time, IQGAP1 signals increased in the dendritic shafts while decreasing in the spines, suggesting that N-cadherin may be required for maintaining IQGAP1/Erk-1/2 interactions in the dendritic spines. In view of the well-established role of IQGAP1 in cellular polarization in developing cells (Noritake et al., 2005) , similar interactions between N-cadherin and IQGAP1 in adult neurons may lead to localized changes in potentiated synapses underlying associative neuronal plasticity (Frey and Morris, 1997) .
In conclusion, we demonstrated that N-cadherin is required for memory formation of contextual fear. Data generated both in vivo and in vitro suggest that these behavioral effects may be based on N-cadherin-mediated interactions of IQGAP1 and Erk-1/2 within the cytoskeleton of dendritic spines. The N-cadherin-regulated cytoskeletal pool of Erk-1/2 may be an important mediator of activity-induced synaptic remodeling (Okamura et al., 2004) and memory formation mechanisms involving actin rearrangement (Fischer et al., 2004) .
EXPERIMENTAL PROCEDURES Animals
Nine-week-old C57BL/6J mice were obtained from Jackson Laboratories. The mice were individually housed in a satellite facility provided with a separate ventilation system (15 air exchanges/hr), a 12/12 dark/light cycle (7 a.m.-7 p.m.), 40%-50% humidity, and 20 C ± 2 C temperature adjacent to the behavioral room. All studies were approved by the Animal Care and Use Committee of Northwestern University in compliance with National Institutes of Health standards. The number of mice per group was 10 to 12 for behavioral, 4 to 5 for immunoblot, and 6 for immunohistochemical experiments.
Peptides
The HAV-N peptide Ala-Arg-Phe-His-Leu-Arg-Ala-His-Ala-Val-AspIle-Asn-Gly-Asn-Gln-Val and a scrambled peptide (HAV-S), Val-AlaVal-Leu-Tyr-Glu-Lys-Ser-Gly-Ile-Ala-Tyr-His-Asn-Ser-Ala-Ser, were synthesized and kindly provided by Lars van Werven (Max Planck Institute for Experimental Medicine, Goettingen). The peptides were dissolved in artificial cerebrospinal fluid immediately before injections at the indicated concentrations.
Cannulation and Injections
Double cannulae were placed into the dorsal hippocampus (anteroposterior À1.5 mm, mediolateral 1 mm, dorsoventral 2 mm) as described earlier (Radulovic et al., 1999) . Injections were delivered bilaterally (0.25 ml/side) over a 30 s period at the indicated doses and times relative to the behavioral task. The cannula position was determined for each mouse by methylene blue injection after the end of experiments, and only data obtained from mice with correctly inserted cannula were analyzed. For all biochemical experiments, the peptides were injected immediately after fear conditioning.
Fear Conditioning
Contextual and tone-dependent fear conditioning was performed in an automated system (TSE Inc.) and consisted of a single exposure to context (3 min) followed by a 30 s tone (10 kHz, 75 dB SPL) and a footshock (2 s, 0.7 mA, constant current) as described previously (Radulovic et al., 1998) . Context-dependent freezing was measured 24 hr later every 10th second over 180 s by two observers unaware of the experimental conditions and expressed as percentage of total number of observations. Freezing to the tone was similarly scored in a novel context during a 3 min exposure. Extinction trials were performed at 24 hr intervals and consisted of nonreinforced 3 min exposures to the context (Fischer et al., 2004) .
Immunohistochemistry
Mice were anesthetized with an intraperitoneal injection of 240 mg/kg of Avertin at the indicated times after training and transcardially perfused with ice-cold 4% paraformaldehyde in phosphate buffer (pH 7.4, 150 ml/mouse). Brains were processed for immunohistochemistry with specific antibodies as described in detail in the Supplemental Experimental Procedures. Quantification of immunostaining signals was performed as described previously (Winder et al., 1999; Sananbenesi et al., 2002) . Digital images were captured with a cooled color CCD camera (RTKE Diagnostic Instruments) and SPOT software for Macintosh. Adobe Photoshop 5.0 for Macintosh was used for image processing. The background corresponding to areas without immunopositive cells was subtracted. Images were binarized and digitally contrast stretched for maximum resolution of N-cadherin-positive cells. The optical density within the CA1 and CA2 subfield and stratum radiatum were determined for each image with the ImageJ software (NIH). The average pixel intensity reflecting the mean value of these three areas was then divided by the total area to determine integrated pixel density. For coimmunolabeling studies, the TSA Fluorescence System (NEN Life Science Products) was employed, using fluorescein as substrate for pErk-1/2 and rhodamine for N-cadherin. Multicolor immunofluorescence was captured using a Zeiss LSM5 Pascal confocal microscope, and z stacks of images were taken using the 103 and 633 objectives and analyzed with a Metamorph software (Macintosh Universal Imaging). The number of coimmunolabeled somas and dendrites was determined as percentage of a total of 100 cells obtained from three captured images per mouse.
Protein Extraction and Immunoblot
Mice were injected with vehicle, HAV-N, or HAV-S immediately after training and euthanized by cervical dislocation 1 hr later. Individual dorsal hippocampi (the rostral 2.5 mm septal pole) were dissected, frozen in liquid nitrogen, and kept at À80 C. Cytoplasmic, membrane, cytoskeletal, and nuclear fractions were prepared by using the ProteoExtract kit for subcellular proteome extraction (EMD Biosciences) according to the instructions. Aliquots of individual samples were stored in loading buffers with or without b-mercaptoethanol (b-ME) for analyses under reducing or nonreducing conditions. The purity of the nuclear, cytoplasmic, and cytoskeletal samples was confirmed by immunoblot with membrane (Na/K ATP-ase), nuclear (CREB), cytoskeletal (b-catenin), and cytoplasmic (LDH) markers ( Figure S2D ). After determining the protein concentration (Bio-Rad), the lysates (5-20 mg/well) were subjected to 10% SDS polyacrylamide gel electrophoresis and subsequently blotted to PVDF membranes (Millipore) as described previously . The membranes were saturated with I-block (Tropix) and then incubated with the primary (Supplemental Experimental Procedures) and corresponding secondary antibodies, enhancer (Nitro-block II, Tropix), and chemiluminescent substrate (CDP Star, Tropix). Blots were exposed to X-ray films and developed in the range of maximal chemiluminescence emission (10 min). Molecular weight and densitometric calculations of pErk-1/2 were performed with the computer software ImageJ (NIH). Interassay variability between blots was determined by a standard control sample for each individual fraction obtained from pooled hippocampi of five naive mice. The levels of individual proteins were normalized to b-actin. The signals of pErk-1/2 were additionally normalized to those of total Erk-1/2 in corresponding individual samples.
Immunoprecipitation Naive mice or mice exposed to fear conditioning were injected i.h. immediately afterwards with vehicle, HAV-S, or HAV-N (n = 9/group). Individual dorsal hippocampi were collected 1 hr later, when HAV-N typically causes a significant decrease of pErk. The hippocampi were lysed in a modified radioimmunoprecipitation buffer, incubated 15 min on ice, and centrifuged for 15 min, 15000 3 g, 4 C as described (Fischer et al., 2007) . After determining the protein concentration for each lysate (Bio-Rad protein assay), 2 mg of total protein/lysate was prepared by pooling three samples of each group. Five hundred micrograms/sample/group was incubated for 1 hr at 4 C with 4 mg anti-Ncadherin, IQGAP1, Erk, or pErk-1/2 antibodies. Immunoprecipitation was performed by the Catch and Release kit (Upstate) as described in the user's manual. Subsequent immunoblot and analyses were performed as described above.
Neuronal Culture and Treatments
Medium density cortical neuron cultures were prepared from rat E18 embryos as described previously (Liao et al., 1999; see Supplemental Experimental Procedures) . Chemical activation of NMDA receptors was preformed at DIV 28 as follows. Neuron cultures were maintained in the presence of 200 mM D,L-amino-phosphonovalerate (D,L-APV). For treatments, neurons were preincubated in aCSF (125 mM NaCl, 2.5 mM KCl, 26.2 mM NaHCO 3 , 1 mM NaH 2 PO 4 , 11 mM glucose, and 2.5 mM CaCl 2 ± 200 mM APV and 1.25 MgCl 2 ) for 30 min at 37 C. Coverslips were also pretreated or not with the peptides HAV-S or HAV-N at a concentration of 200 mM for 2 hr. Following a wash in treatment medium (aCSF plus 10 mM glycine, 100 mM picrotoxin, and 1 mM strychnine), coverslips were transferred to the treatment chambers in aCSF ± peptides. Treatments were allowed to proceed for the indicated times, after which cells were fixed for 10 min with methanol chilled to À20 C. Coverslips were then processed for immunostaining and analyses as previously described (Penzes et al., 2003; see Supplemental Experimental Procedures) .
Data Analysis
Statistically significant differences were determined by Student's t test, or one-way (factor Treatment) and two-way (factors Dose 3 Time) ANOVA, followed by Scheffe's test for post hoc comparisons. The results are presented as mean ± SEM.
Supplemental Data
The Supplemental Data for this article can be found online at http:// www.neuron.org/cgi/content/full/55/5/786/DC1/.
